CS196349B2 - Process for preparing heparine - Google Patents
Process for preparing heparine Download PDFInfo
- Publication number
- CS196349B2 CS196349B2 CS771523A CS152377A CS196349B2 CS 196349 B2 CS196349 B2 CS 196349B2 CS 771523 A CS771523 A CS 771523A CS 152377 A CS152377 A CS 152377A CS 196349 B2 CS196349 B2 CS 196349B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- heparin
- gel
- specific activity
- antithrombin
- matrix
- Prior art date
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 229920000669 heparin Polymers 0.000 title claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960002897 heparin Drugs 0.000 claims abstract description 48
- 230000000694 effects Effects 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 239000003463 adsorbent Substances 0.000 claims abstract description 5
- 108010017384 Blood Proteins Proteins 0.000 claims abstract 3
- 102000004506 Blood Proteins Human genes 0.000 claims abstract 3
- 239000004019 antithrombin Substances 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 108010093564 inter-alpha-inhibitor Proteins 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims 2
- 239000011543 agarose gel Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 abstract description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000000872 buffer Substances 0.000 description 13
- 239000007983 Tris buffer Substances 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- KKNIUBFRGPFELP-UHFFFAOYSA-N secretolin Chemical compound N=1C=CNC=1CC(N)C(=O)NC(CO)C(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(C(C)O)C(=O)NC(C(=O)NC(C(=O)NC(CO)C(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(O)=O)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(O)=O)C(C)O)CC1=CC=CC=C1 KKNIUBFRGPFELP-UHFFFAOYSA-N 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 102000013831 Coagulation factor IX Human genes 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 229940105774 coagulation factor ix Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- FNEHAOQZWPHONV-UHFFFAOYSA-N 9h-carbazole;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C3=CC=CC=C3NC2=C1 FNEHAOQZWPHONV-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 102000022382 heparin binding proteins Human genes 0.000 description 1
- 108091012216 heparin binding proteins Proteins 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7603040A SE431218B (sv) | 1976-03-05 | 1976-03-05 | Forfarande for rening av heparin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS196349B2 true CS196349B2 (en) | 1980-03-31 |
Family
ID=20327240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS771523A CS196349B2 (en) | 1976-03-05 | 1977-03-07 | Process for preparing heparine |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS52108012A (de) |
| AT (1) | AT356818B (de) |
| AU (1) | AU508430B2 (de) |
| CA (1) | CA1079272A (de) |
| CS (1) | CS196349B2 (de) |
| DE (1) | DE2709500C2 (de) |
| DK (1) | DK155606C (de) |
| ES (1) | ES456196A1 (de) |
| FI (1) | FI62103C (de) |
| FR (1) | FR2342991A1 (de) |
| GB (1) | GB1539332A (de) |
| HU (1) | HU176811B (de) |
| IE (1) | IE44907B1 (de) |
| IL (1) | IL51346A (de) |
| NL (1) | NL186385C (de) |
| NO (1) | NO144388C (de) |
| NZ (1) | NZ183480A (de) |
| PL (1) | PL103049B1 (de) |
| SE (1) | SE431218B (de) |
| SU (1) | SU736860A3 (de) |
| ZA (1) | ZA771267B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE449753B (sv) * | 1978-11-06 | 1987-05-18 | Choay Sa | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav |
| GB2164346B (en) * | 1984-08-31 | 1988-03-30 | Nicolas Huberto Behrens | A non-thrombogenic heparin and a process for its obtention |
| WO2015112121A1 (en) | 2014-01-21 | 2015-07-30 | The Board Of Trustees Of The University Of Arkansas | Heparin affinity tag for use in protein purification |
| CN119039480A (zh) * | 2024-11-01 | 2024-11-29 | 山东万邦赛诺康生化制药股份有限公司 | 一种肝素钠酶解精制方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2623001A (en) * | 1949-04-07 | 1952-12-23 | Bengt E G V Sylven | Preparing heparin |
| DE1195010B (de) * | 1962-05-12 | 1965-06-16 | Ormonoterapia Richter S P A | Verfahren zur Reinigung von Heparin nach der Chromatographischen Methode |
-
1976
- 1976-03-05 SE SE7603040A patent/SE431218B/xx not_active IP Right Cessation
-
1977
- 1977-01-27 IL IL51346A patent/IL51346A/xx unknown
- 1977-02-14 CA CA271,731A patent/CA1079272A/en not_active Expired
- 1977-02-15 FI FI770491A patent/FI62103C/fi not_active IP Right Cessation
- 1977-02-22 NL NLAANVRAGE7701882,A patent/NL186385C/xx not_active IP Right Cessation
- 1977-02-23 ES ES456196A patent/ES456196A1/es not_active Expired
- 1977-02-25 JP JP2016477A patent/JPS52108012A/ja active Pending
- 1977-03-02 NZ NZ183480A patent/NZ183480A/xx unknown
- 1977-03-03 IE IE469/77A patent/IE44907B1/en not_active IP Right Cessation
- 1977-03-03 ZA ZA00771267A patent/ZA771267B/xx unknown
- 1977-03-04 DK DK096077A patent/DK155606C/da not_active IP Right Cessation
- 1977-03-04 AU AU22953/77A patent/AU508430B2/en not_active Expired
- 1977-03-04 PL PL1977196438A patent/PL103049B1/pl unknown
- 1977-03-04 SU SU772457090A patent/SU736860A3/ru active
- 1977-03-04 AT AT144577A patent/AT356818B/de not_active IP Right Cessation
- 1977-03-04 NO NO770764A patent/NO144388C/no unknown
- 1977-03-04 FR FR7706469A patent/FR2342991A1/fr active Granted
- 1977-03-04 HU HU77KA1485A patent/HU176811B/hu unknown
- 1977-03-04 GB GB9275/77A patent/GB1539332A/en not_active Expired
- 1977-03-04 DE DE2709500A patent/DE2709500C2/de not_active Expired
- 1977-03-07 CS CS771523A patent/CS196349B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI62103C (fi) | 1982-11-10 |
| DE2709500C2 (de) | 1986-09-18 |
| NL186385B (nl) | 1990-06-18 |
| NO770764L (no) | 1977-09-06 |
| AU508430B2 (en) | 1980-03-20 |
| DK96077A (da) | 1977-09-06 |
| SE431218B (sv) | 1984-01-23 |
| DK155606C (da) | 1989-09-11 |
| IL51346A (en) | 1979-11-30 |
| AU2295377A (en) | 1978-09-07 |
| NZ183480A (en) | 1979-08-31 |
| PL103049B1 (pl) | 1979-05-31 |
| IL51346A0 (en) | 1977-03-31 |
| FI770491A7 (de) | 1977-09-06 |
| DK155606B (da) | 1989-04-24 |
| SE7603040L (sv) | 1977-09-06 |
| NO144388C (no) | 1981-08-19 |
| FI62103B (fi) | 1982-07-30 |
| FR2342991B1 (de) | 1981-10-30 |
| ES456196A1 (es) | 1978-07-01 |
| DE2709500A1 (de) | 1977-09-08 |
| SU736860A3 (ru) | 1980-05-25 |
| ATA144577A (de) | 1979-10-15 |
| NO144388B (no) | 1981-05-11 |
| NL186385C (nl) | 1990-11-16 |
| HU176811B (en) | 1981-05-28 |
| CA1079272A (en) | 1980-06-10 |
| JPS52108012A (en) | 1977-09-10 |
| GB1539332A (en) | 1979-01-31 |
| ZA771267B (en) | 1978-01-25 |
| IE44907B1 (en) | 1982-05-19 |
| IE44907L (en) | 1977-09-05 |
| NL7701882A (nl) | 1977-09-07 |
| AT356818B (de) | 1980-05-27 |
| FR2342991A1 (fr) | 1977-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3842061A (en) | Method for isolation of antithrombin from animal tissue materials by adsorption on sulfated carbohydrate gel | |
| US3920625A (en) | Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates | |
| EP0792281B1 (de) | Verfahren zur reinigung von faktor viii | |
| US4119774A (en) | Heparin purification method | |
| Danishefsky et al. | Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor | |
| FI95136C (fi) | Menetelmä anneksiinien puhdistamiseksi | |
| JPH0150208B2 (de) | ||
| US4689323A (en) | Covalently bound heparin--antithrombin-III complex | |
| JPH0580455B2 (de) | ||
| CA1211371A (en) | Method of producing an antithrombin iii-heparin concentrate or an antithrombin iii-heparinoid concentrate | |
| ES2743711T3 (es) | Un proceso para la reducción y/o retirada de FXI y FXIa de soluciones que contienen fichos factores de coagulación | |
| JP2511500B2 (ja) | 胎盤組織タンパク質ｐｐ▲下４▼の精製法 | |
| CS196349B2 (en) | Process for preparing heparine | |
| JPH02113893A (ja) | 凝固因子２、７、９およびｘの１または２以上を濃縮する方法 | |
| JP3745805B2 (ja) | トロンボモジュリンの精製方法 | |
| EP0048898B1 (de) | Verfahren zur Herstellung eines Antithrombin-Heparin-Komplexes sowie diesen Komplex enthaltende pharmazeutische Mischungen | |
| JPH0423751B2 (de) | ||
| JP2001097997A (ja) | 硫酸化ヒアルロン酸を用いたアフィニティー吸着担体及びその使用 | |
| SU1419717A1 (ru) | Способ получени биоспецифических адсорбентов дл выделени фибронектина и коллагеназ | |
| JPH08176199A (ja) | アフィニティークロマトグラフィーを用いたヒルジンの精製法 | |
| CA2035927A1 (en) | Process for purifying lipocortins | |
| JPH0459796A (ja) | アフィニティークロマトグラフィー用担体およびアンチトロンビン３の精製方法 | |
| JPS5813390A (ja) | 高純度ウロキナ−ゼの分離精製法 |